Clinical Trial

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The extent of hepatic resection for gallbladder cancer can be done from a wedge resection to 4b/5 bisegmentectomy. This study aims to compare the recurrence rates and survival rates between wedge resection group and bisegmentectomy group. Patients with T2 or T3 gallbladder cancer on preoperative CT exam or patients who were pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy were enrolled. All patients are randomly assigned to wedge resection or bisegmentectomy group. Number of patients in each group is 44. Primary endpoint is recurrence-free-survival rates and overall survival rates.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2016-09-28.
Trial Details
NCT Number NCT02920554
Lead Sponsor Saint Vincent's Hospital, Korea
Conditions Gallbladder Cancer
Enrollment 88 participants
Start Date 2014-07
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2024-05-22